Keren Osman

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Mahmoud Elsawy, Julio C. Chávez, Irit Avivi et al. · Blood · 2022 · 75 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19

Michael E. Bowdish, Christina E. Barkauskas, Jessica Overbey et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 71 citations · Full text

Medicine, Immunology, Internal Medicine +17

<scp>Real‐world</scp> evidence of the safety and survival with <scp>CD19 CAR‐T</scp> cell therapy for relapsed/refractory solid organ <scp>transplant‐related PTLD</scp>

Marshall McKenna, Narendranath Epperla, Armin Ghobadi et al. · British Journal of Haematology · 2023 · 37 citations · Full text

Life Sciences, Hematology, Immunology +14

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019

Stacey-Ann Whittaker Brown, Camelia Iancu‐Rubin, Adam Aboelela et al. · Cytotherapy · 2022 · 10 citations · Full text

Medicine, Immunology, Infectious Diseases +16